A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers

Clinical trial NCT02561871 · COMPLETED

Trial details

NCT number: NCT02561871
Sponsor: Crucell Holland BV
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Viruses Respiratory Tract Infections

Start date: 2015-09-01
Primary completion: 2016-09-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.